Abstract
Purpose
This report is a review of findings on the diagnosis, treatment, clinical course, follow-up, and prognosis of craniopharyngioma patients with special regard to clinical trials and long-term management.
Methods
Literature search on Pubmed for paper published after 1994.
Results
Craniopharyngiomas are rare, embryonic malformations of the sellar/parasellar region with low histological grade. Clinical manifestations are related to increased intracranial pressure, visual impairment, and hypothalamic/pituitary deficiencies. If the tumor is favorably localized, therapy of choice is complete resection, with care taken to preserve hypothalamic and optic functions. In patients with unfavorable tumor location (i.e. involvement of hypothalamic areas), recommended therapy is limited hypothalamus-sparing surgical strategy followed by irradiation. Irradiation has proven effective in treatment of recurrences and progression. Surgical lesions and/or anatomical involvement of posterior hypothalamic areas can result in serious sequelae, mainly hypothalamic syndrome.
Conclusions
It is crucial that craniopharyngioma be managed as a frequently chronic disease, providing ongoing care of pediatric and adult patients’ by experienced multidisciplinary teams in the context of multicenter trials.
Similar content being viewed by others
References
Muller HL (2010) Childhood craniopharyngioma–current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol 6(11):609–618. doi:10.1038/nrendo.2010.168
Muller HL (2013) Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nat Rev Endocrinol 9(8):447–449. doi:10.1038/nrendo.2013.125
Muller HL (2014) Craniopharyngioma. Endocr Rev 35(3):513–543. doi:10.1210/er.2013-1115
Daubenbuchel AM, Muller HL (2015) Neuroendocrine disorders in pediatric craniopharyngioma patients. J Clin Med 4(3):389–413. doi:10.3390/jcm4030389
Muller HL (2016) Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome. Endocrine 51(1):1–3. doi:10.1007/s12020-015-0800-x
Muller HL (2016) Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 23(1):81–89. doi:10.1097/MED.0000000000000214
Muller HL (2014) Craniopharyngioma. Handb Clin Neurol 124:235–253. doi:10.1016/B978-0-444-59602-4.00016-2
Karavitaki N (2014) Management of craniopharyngiomas. J Endocrinol Investig 37(3):219–228. doi:10.1007/s40618-013-0050-9
Bereket A, Kiess W, Lustig RH, Muller HL, Goldstone AP, Weiss R, Yavuz Y, Hochberg Z (2012) Hypothalamic obesity in children. Obes Rev 13(9):780–798. doi:10.1111/j.1467-789X.2012.01004.x
Muller HL (2011) Diagnostics, treatment, and follow-up in craniopharyngioma. Front Endocrinol (Lausanne) 2:70. doi:10.3389/fendo.2011.00070
Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, Jorgensen JO, Bjerre P, Andersen M, Andersen C, Jorgensen J, Lindholm J, Laurberg P (2011) Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 104(3):755–763. doi:10.1007/s11060-011-0540-6
Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89(4):547–551. doi:10.3171/jns.1998.89.4.0547
Muller-Scholden J, Lehrnbecher T, Muller HL, Bensch J, Hengen RH, Sorensen N, Stockhausen HB (2000) Radical surgery in a neonate with craniopharyngioma. Report of a case. Pediatr Neurosurg 33(5):265–269
Kordes U, Flitsch J, Hagel C, Goebell E, Schwarz R, Herberhold T, von Bueren AO, Rutkowski S, Muller HL (2011) Ectopic craniopharyngioma. Klin Padiatr 223(3):176–177. doi:10.1055/s-0031-1273743
Hoffmann A, Brentrup A, Muller HL (2016) First report on spinal metastasis in childhood-onset craniopharyngioma. J Neurooncol. doi:10.1007/s11060-016-2160-7
Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kuhl J, Gutjahr P, Sorensen N, Calaminus G (2001) Obesity after childhood craniopharyngioma–German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213(4):244–249. doi:10.1055/s-2001-16855
Muller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sorensen N (2003) Perioperative dexamethasone treatment in childhood craniopharyngioma–influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes 111(6):330–334. doi:10.1055/s-2003-42722
Sklar CA (1994) Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 21(Suppl 1):18–20
Muller HL (2008) Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 69(4):193–202. doi:10.1159/000113019
Elliott RE, Jane JA Jr, Wisoff JH (2011) Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery 69(3):630–643. doi:10.1227/NEU.0b013e31821a872d (discussion 643)
Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89(7):3298–3305. doi:10.1210/jc.2003-031751
Hoffmann A, Boekhoff S, Gebhardt U, Sterkenburg AS, Daubenbuchel AM, Eveslage M, Muller HL (2015) History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis. Eur J Endocrinol 173(6):853–862. doi:10.1530/EJE-15-0709
De Vile CJ, Grant DB, Kendall BE, Neville BG, Stanhope R, Watkins KE, Hayward RD (1996) Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg 85(1):73–81. doi:10.3171/jns.1996.85.1.0073
Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C, Busiah K, Laborde K, Boddaert N, Zerah M, Alapetite C, Grill J, Touraine P, Sainte-Rose C, Polak M, Puget S (2013) Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab 98(6):2376–2382. doi:10.1210/jc.2012-3928
Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl):3–12. doi:10.3171/ped.2007.106.1.3
Garre ML, Cama A (2007) Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr 19(4):471–479. doi:10.1097/MOP.0b013e3282495a22
Muller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, Calaminus G, Sorensen N (2012) Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab 97(11):3935–3943. doi:10.1210/jc.2012-2069
Muller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sorensen N, Calaminus G (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 165(1):17–24. doi:10.1530/EJE-11-0158
Mallucci C, Pizer B, Blair J, Didi M, Doss A, Upadrasta S, Newman W, Avula S, Pettorini B (2012) Management of craniopharyngioma: the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system. Childs Nerv Syst 28(8):1181–1192. doi:10.1007/s00381-012-1787-8
Mortini P, Gagliardi F, Bailo M, Spina A, Parlangeli A, Falini A, Losa M (2016) Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas. Endocrine 51(1):148–162. doi:10.1007/s12020-015-0683-x
Van Gompel JJ, Nippoldt TB, Higgins DM, Meyer FB (2010) Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity. Neurosurg Focus 28(4):E3. doi:10.3171/2010.1.FOCUS09303
Muller HL (2011) Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab 96(7):1981–1991. doi:10.1210/jc.2011-0174
Muller HL (2015) Craniopharyngioma: long-term consequences of a chronic disease. Exp Rev Neurother 15(11):1241–1244. doi:10.1586/14737175.2015.1100078
Sanford RA (1994) Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg 21(Suppl 1):39–43
Boop FA (2007) Craniopharyngioma. J Neurosurg 106(1 Suppl):1–2. doi:10.3171/ped.2007.106.1.1 (discussion 2)
Hankinson TC, Palmeri NO, Williams SA, Torok MR, Serrano CA, Foreman NK, Handler MH, Liu AK (2013) Patterns of care for craniopharyngioma: survey of members of the american association of neurological surgeons. Pediatr Neurosurg 49(3):131–136. doi:10.1159/000357783
Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G, Muller HL (2014) Childhood craniopharyngioma—changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klin Padiatr 226(3):161–168. doi:10.1055/s-0034-1368785
Rath SR, Lee S, Kotecha RS, Taylor M, Junckerstorff RC, Choong CS (2013) Childhood craniopharyngioma: 20-year institutional experience in Western Australia. J Paediatr Child Health 49(5):403–408. doi:10.1111/jpc.12190
Lo AC, Howard AF, Nichol A, Sidhu K, Abdulsatar F, Hasan H, Goddard K (2014) Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience. Int J Radiat Oncol Biol Phys 88(5):1011–1018. doi:10.1016/j.ijrobp.2014.01.019
Zaidi HA, Chapple K, Little AS (2014) National treatment trends, complications, and predictors of in-hospital charges for the surgical management of craniopharyngiomas in adults from 2007 to 2011. Neurosurg Focus 37(5):E6. doi:10.3171/2014.8.FOCUS14366
Muller HL (2014) Childhood craniopharyngioma: treatment strategies and outcomes. Exp Rev Neurother 14(2):187–197. doi:10.1586/14737175.2014.875470
Flitsch J, Aberle J, Burkhardt T (2015) Surgery for pediatric craniopharyngiomas: is less more? J Pediatr Endocrinol Metab 28(1–2):27–33. doi:10.1515/jpem-2014-0417
Buchfelder M, Schlaffer SM, Lin F, Kleindienst A (2013) Surgery for craniopharyngioma. Pituitary 16(1):18–25. doi:10.1007/s11102-012-0414-8
Mortini P, Gagliardi F, Boari N, Losa M (2013) Surgical strategies and modern therapeutic options in the treatment of craniopharyngiomas. Crit Rev Oncol Hematol 88(3):514–529. doi:10.1016/j.critrevonc.2013.07.013
Ali ZS, Bailey RL, Daniels LB, Vakhshori V, Lewis DJ, Hossain AT, Sitterley KY, Lee JY, Storm PB, Heuer GG, Stein SC (2014) Comparative effectiveness of treatment options for pediatric craniopharyngiomas. J Neurosurg Pediatr 13(2):178–188. doi:10.3171/2013.11.PEDS1320
Ogawa Y, Kawaguchi T, Tominaga T (2014) Outcome and mid-term prognosis after maximum and radical removal of craniopharyngiomas with the priority to the extended transsphenoidal approach–a single center experience. Clin Neurol Neurosurg 125:41–46. doi:10.1016/j.clineuro.2014.07.014
Raza SM, Schwartz TH (2014) How to achieve the best possible outcomes in the management of retroinfundibular craniopharyngiomas? World Neurosurg 82(5):614–616. doi:10.1016/j.wneu.2014.03.029
Flitsch J, Muller HL, Burkhardt T (2011) Surgical strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne) 2:96. doi:10.3389/fendo.2011.00096
Caldarelli M, Massimi L, Tamburrini G, Cappa M, Di Rocco C (2005) Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Childs Nerv Syst 21(8–9):747–757. doi:10.1007/s00381-005-1186-5
Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI (1992) Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76(1):47–52. doi:10.3171/jns.1992.76.1.0047
Honegger J, Buchfelder M, Fahlbusch R (1999) Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 90(2):251–257. doi:10.3171/jns.1999.90.2.0251
Elliott RE, Wisoff JH (2010) Surgical management of giant pediatric craniopharyngiomas. J Neurosurg Pediatr 6(5):403–416. doi:10.3171/2010.8.PEDS09385
Steno J, Bizik I, Steno A, Matejcik V (2011) Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv Syst 27(1):41–54. doi:10.1007/s00381-010-1330-8
Jung TY, Jung S, Moon KS, Kim IY, Kang SS, Kim JH (2010) Endocrinological outcomes of pediatric craniopharyngiomas with anatomical pituitary stalk preservation: preliminary study. Pediatr Neurosurg 46(3):205–212. doi:10.1159/000318426
Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, Lustig RH, Kun LE (2002) Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001. Int J Radiat Oncol Biol Phys 53(3):533–542
Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E (2004) Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46(4):220–229
Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT, Hamilton J (2006) Weight gain in craniopharyngioma—a model for hypothalamic obesity. J Pediatr Endocrinol Metab 19(2):121–127
Mortini P, Losa M, Pozzobon G, Barzaghi R, Riva M, Acerno S, Angius D, Weber G, Chiumello G, Giovanelli M (2011) Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg 114(5):1350–1359. doi:10.3171/2010.11.JNS10670
Halac I, Zimmerman D (2005) Endocrine manifestations of craniopharyngioma. Childs Nerv Syst 21(8–9):640–648. doi:10.1007/s00381-005-1246-x
Crom D, Smith D, Xiong Z, Onar A, Hudson M, Merchant T, Morris E (2010) Health status in long-term survivors of pediatric craniopharyngiomas. Am Assoc Neurosci Nurses 42(6):323–328
Geffner M, Lundberg M, Koltowska-Haggstrom M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B (2004) Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 89(11):5435–5440. doi:10.1210/jc.2004-0667
Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT (2004) Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89(1):81–86
Matson DD (1964) Craniopharyngioma. Clin Neurosurg 10:14
Fjalldal S, Holmer H, Rylander L, Elfving M, Ekman B, Osterberg K, Erfurth EM (2013) Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab 98(8):3253–3262. doi:10.1210/jc.2013-2000
Steno J, Bizik I, Steno A, Matejcik V (2013) Craniopharyngiomas and the hypothalamus. J Neurosurg 119(6):1646–1650. doi:10.3171/2013.5.JNS131047
Rosenfeld A, Arrington D, Miller J, Olson M, Gieseking A, Etzl M, Harel B, Schembri A, Kaplan A (2014) A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol 50(1):4–10. doi:10.1016/j.pediatrneurol.2013.09.003
Khan MJ, Humayun KN, Donaldson M, Ahmed SF, Shaikh MG (2014) Longitudinal changes in body mass index in children with craniopharyngioma. Horm Res Paediatr 82(6):372–379. doi:10.1159/000368798
Erfurth EM (2015) Endocrine aspects and sequel in patients with craniopharyngioma. J Pediatr Endocrinol Metab 28(1–2):19–26. doi:10.1515/jpem-2014-0419
Muller HL (2010) Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up. Exp Rev Neurother 10(4):515–524. doi:10.1586/ern.10.15
Muller HL, Gebhardt U, Schroder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sorensen N (2010) Analyses of treatment variables for patients with childhood craniopharyngioma–results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr 73(3):175–180. doi:10.1159/000284358
Roth CL, Eslamy H, Werny D, Elfers C, Shaffer ML, Pihoker C, Ojemann J, Dobyns WB (2015) Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity. Obesity (Silver Spring) 23(6):1226–1233. doi:10.1002/oby.21067
Muller HL (2010) Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol 2010:519607. doi:10.1155/2010/519607
Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AM, Muller HL (2015) Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17(7):1029–1038. doi:10.1093/neuonc/nov044
Kim JH, Choi JH (2013) Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents. Ann Pediatr Endocrinol Metab 18(4):161–167. doi:10.6065/apem.2013.18.4.161
Cohen M, Syme C, McCrindle BW, Hamilton J (2013) Autonomic nervous system balance in children and adolescents with craniopharyngioma and hypothalamic obesity. Eur J Endocrinol 168(6):845–852. doi:10.1530/EJE-12-1082
Haliloglu B, Bereket A (2015) Hypothalamic obesity in children: pathophysiology to clinical management. J Pediatr Endocrinol Metab 28(5–6):503–513. doi:10.1515/jpem-2014-0512
Harz KJ, Muller HL, Waldeck E, Pudel V, Roth C (2003) Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88(11):5227–5231
Muller HL, Handwerker G, Gebhardt U, Faldum A, Emser A, Kolb R, Sorensen N (2006) Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control 17(4):583–589. doi:10.1007/s10552-005-9012-7
Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N (2002) Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87(8):3993–3996
O’Gorman CS, Simoneau-Roy J, Pencharz P, MacFarlane J, MacLusky I, Narang I, Adeli K, Daneman D, Hamilton J (2010) Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls. J Clin Endocrinol Metab 95(5):2211–2218. doi:10.1210/jc.2009-2003
Muller HL, Muller-Stover S, Gebhardt U, Kolb R, Sorensen N, Handwerker G (2006) Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. J Pediatr Endocrinol Metab 19(Suppl 1):423–429
Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatri Adolesc Med 156(9):887–892
Roth CL, Hunneman DH, Gebhardt U, Stoffel-Wagner B, Reinehr T, Muller HL (2007) Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatr Res 61(4):496–501. doi:10.1203/pdr.0b013e3180332cd6
Roth CL (2011) Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits. Front Endocrinol (Lausanne) 2:49. doi:10.3389/fendo.2011.00049
Bomer I, Saure C, Caminiti C, Ramos JG, Zuccaro G, Brea M, Bravo M, Maza C (2015) Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity. J Pediatr Endocrinol Metab 28(11–12):1305–1312. doi:10.1515/jpem-2015-0167
Holmer H, Pozarek G, Wirfalt E, Popovic V, Ekman B, Bjork J, Erfurth EM (2010) Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab 95(12):5395–5402. doi:10.1210/jc.2010-0993
Prieto R, Pascual JM, Barrios L (2015) Optic chiasm distortions caused by craniopharyngiomas: clinical and magnetic resonance imaging correlation and influence on visual outcome. World Neurosurg 83(4):500–529. doi:10.1016/j.wneu.2014.10.002
Drimtzias E, Falzon K, Picton S, Jeeva I, Guy D, Nelson O, Simmons I (2014) The ophthalmic natural history of paediatric craniopharyngioma: a long-term review. J Neurooncol 120(3):651–656. doi:10.1007/s11060-014-1600-5
Roth CL, Elfers C, Gebhardt U, Muller HL, Reinehr T (2013) Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss. Metabolism 62(2):226–234. doi:10.1016/j.metabol.2012.08.001
Roth CL, Enriori PJ, Gebhardt U, Hinney A, Muller HL, Hebebrand J, Reinehr T, Cowley MA (2010) Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity. Metabolism 59(2):186–194. doi:10.1016/j.metabol.2009.06.031
Roemmler-Zehrer J, Geigenberger V, Stormann S, Losa M, Crippa V, Otto B, Bidlingmaier M, Dimopoulou C, Stalla GK, Schopohl J (2014) Food intake regulating hormones in adult craniopharyngioma patients. Eur J Endocrinol 170(4):627–635. doi:10.1530/EJE-13-0832
Roth CL, Gebhardt U, Muller HL (2011) Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring) 19(1):36–42. doi:10.1038/oby.2010.80
Roth C, Wilken B, Hanefeld F, Schroter W, Leonhardt U (1998) Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138(1):89–91
Hoffmann A, Bootsveld K, Gebhardt U, Daubenbuchel AM, Sterkenburg AS, Muller HL (2015) Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. Eur J Endocrinol 173(3):389–397. doi:10.1530/EJE-15-0422
Muller HL (2013) Childhood craniopharyngioma. Pituitary 16(1):56–67. doi:10.1007/s11102-012-0401-0
Lustig RH (2011) Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne) 2:60. doi:10.3389/fendo.2011.00060
Elfers CT, Roth CL (2011) Effects of methylphenidate on weight gain and food intake in hypothalamic obesity. Front Endocrinol (Lausanne) 2:78. doi:10.3389/fendo.2011.00078
Hamilton JK, Conwell LS, Syme C, Ahmet A, Jeffery A, Daneman D (2011) Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy. Int J Pediatr Endocrinol 2011:417949. doi:10.1155/2011/417949
Zoicas F, Droste M, Mayr B, Buchfelder M, Schofl C (2013) GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases. Eur J Endocrinol 168(5):699–706. doi:10.1530/EJE-12-0997
Profka E, Giavoli C, Bergamaschi S, Ferrante E, Malchiodi E, Sala E, Verrua E, Rodari G, Filopanti M, Beck-Peccoz P, Spada A (2015) Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma. J Endocrinol Investig 38(4):413–420. doi:10.1007/s40618-014-0196-0
Yuen KC, Koltowska-Haggstrom M, Cook DM, Fox JL, Jonsson PJ, Geffner ME, Abs R (2013) Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction. Eur J Endocrinol 169(4):511–519. doi:10.1530/EJE-13-0280
Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88(6):2586–2592
Bretault M, Boillot A, Muzard L, Poitou C, Oppert JM, Barsamian C, Gatta B, Muller H, Weismann D, Rottembourg D, Inge T, Veyrie N, Carette C, Czernichow S (2013) Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab 98(6):2239–2246. doi:10.1210/jc.2012-4184
Gatta B, Nunes ML, Bailacq-Auder C, Etchechoury L, Collet D, Tabarin A (2013) Is bariatric surgery really inefficient in hypothalamic obesity? Clin Endocrinol 78(4):636–638. doi:10.1111/cen.12031
Muller HL, Gebhardt U, Wessel V, Schroder S, Kolb R, Sorensen N, Maroske J, Hanisch E (2007) First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Padiatr 219(6):323–325. doi:10.1055/s-2007-985848
Muller HL, Gebhardt U, Maroske J, Hanisch E (2011) Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB). Klin Padiatr 223(6):372–373. doi:10.1055/s-0031-1284420
Schultes B, Ernst B, Schmid F, Thurnheer M (2009) Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur J Endocrinol 161(1):201–206. doi:10.1530/EJE-09-0079
Rottembourg D, O’Gorman CS, Urbach S, Garneau PY, Langer JC, Van Vliet G, Hamilton J, Huot C (2009) Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab 22(9):867–872
Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, Kleinschmidt-DeMasters BK, Johnston JM, Anderson RC, Rosenfeld A, Handler M, Gore L, Foreman N, Hankinson TC (2015) Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun 3:30. doi:10.1186/s40478-015-0211-5
Sterkenburg AS, Hoffmann A, Gebhardt U, Waldeck E, Springer S, Muller HL (2014) Childhood craniopharyngioma with hypothalamic obesity-no long-term weight reduction due to rehabilitation programs. Klin Padiatr 226(6–7):344–350. doi:10.1055/s-0034-1387747
Hoffmann A, Postma FP, Sterkenburg AS, Gebhardt U, Muller HL (2015) Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma. J Pediatr Endocrinol Metab 28(1–2):35–43. doi:10.1515/jpem-2014-0415
Roth CL, Aylward E, Liang O, Kleinhans NM, Pauley G, Schur EA (2012) Functional neuroimaging in craniopharyngioma: a useful tool to better understand hypothalamic obesity? Obes Facts 5(2):243–253. doi:10.1159/000338695
Roemmler-Zehrer J, Geigenberger V, Stormann S, Ising M, Pfister H, Sievers C, Stalla GK, Schopohl J (2015) Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma. Clin Endocrinol 82(1):106–114. doi:10.1111/cen.12523
Kilday JP, Bartels U, Huang A, Barron M, Shago M, Mistry M, Zhukova N, Laperriere N, Dirks P, Hawkins C, Bouffet E, Tabori U (2014) Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach. J Neuro Oncol 116(1):195–204. doi:10.1007/s11060-013-1284-2
Hoffmann A, Gebhardt U, Sterkenburg AS, Warmuth-Metz M, Muller HL (2014) Diencephalic syndrome in childhood craniopharyngioma-results of german multicenter studies on 485 long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab 99(11):3972–3977. doi:10.1210/jc.2014-1680
Van Effenterre R, Boch AL (2002) Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 97(1):3–11. doi:10.3171/jns.2002.97.1.0003
Muller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N (2003) Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. Klin Padiatr 215(6):310–314. doi:10.1055/s-2003-45499
Muller HL, Bruhnken G, Emser A, Faldum A, Etavard-Gorris N, Gebhardt U, Kolb R, Sorensen N (2005) Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv Syst 21(11):975–980. doi:10.1007/s00381-004-1124-y
Muller HL, Gebhardt U, Faldum A, Emser A, Etavard-Gorris N, Kolb R, Sorensen N (2005) Functional capacity and body mass index in patients with sellar masses—cross-sectional study on 403 patients diagnosed during childhood and adolescence. Childs Nerv Syst 21(7):539–545. doi:10.1007/s00381-005-1166-9
Muller HL, Gebhardt U, Etavard-Gorris N, Korenke E, Warmuth-Metz M, Kolb R, Sorensen N, Calaminus G (2004) Prognosis and sequela in patients with childhood craniopharyngioma—results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin Padiatr 216(6):343–348. doi:10.1055/s-2004-832339
Ondruch A, Maryniak A, Kropiwnicki T, Roszkowski M, Daszkiewicz P (2011) Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma. Childs Nerv Syst 27(3):391–397
Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P (1990) Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73(1):3–11. doi:10.3171/jns.1990.73.1.0003
Cavazzuti V, Fischer E, Welch K, Belli J, Winston K (1983) Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children. J Neurosurg 59(3):409–417
Riva D, Pantaleoni C, Devoti M, Saletti V, Nichelli F, Giorgi C (1998) Late neuropsychological and behavioral outcome of children surgically treated for craniopharyngioma. Childs Nerv Syst 14:179–184
Kiehna E, Mulhern R, Li C, Xiong X, Merchant T (2006) Changes in attentional performance of children and young adults iwth localized primary brain tumors after conformal radiation therapy. J Clin Oncol 24(33):5283–5290
Carpentieri S, Waber D, Scott R, Goumnerova L, Kieran M, Cohen L, Kim F, Billett A, Tarbell N, Pomeroy S (2001) Memory deficits among children with craniopharyngioma. Neurosurgery 49(5):1053–1058
Sands S, Milner J, Goldberg J, Mukhi V, Moliterno J, Maxfield C, Wisoff J (2005) Quality of life and behavioral follow-up study of pediatric survivors of cranipharyngioma. J Neurosurg Pediatr 103:302–311
Ozyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, Warmuth-Metz M, Muller HL (2014) Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr 164(4):876–881. doi:10.1016/j.jpeds.2013.12.010
Colangelo M, Ambrosio A, Ambrosio C (1990) Neurological and behavioral sequelae following different approaches to craniopharyngioma. Long-term follow-up review and therapeutic guidelines. Childs Nerv Syst 6(7):379–382
Metzler-Baddeley C, Jones R (2010) Brief communication: cognitive rehabilitation of executive functioning in a case of craniopharyngioma. Appl Neuropsychol 17:299–304
Hammond J, Hall S (2011) Functional analysis and treatment of aggressive behavior following resection of a craniopharyngioma. Dev Med Child Neurol 53:369–374
Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ (1993) 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27(2):189–195
Liu AK, Bagrosky B, Fenton LZ, Gaspar LE, Handler MH, McNatt SA, Foreman NK (2009) Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy. Pediatr Blood Cancer 52(2):227–230. doi:10.1002/pbc.21787
Regine WF, Kramer S (1992) Pediatric craniopharyngiomas: long term results of combined treatment with surgery and radiation. Int J Radiat Oncol Biol Phys 24(4):611–617
Rajan B, Ashley S, Gorman C, Jose CC, Horwich A, Bloom HJ, Marsh H, Brada M (1993) Craniopharyngioma–a long-term results following limited surgery and radiotherapy. Radiother Oncol 26(1):1–10
Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, Rorke LB, Phillips PC, Sutton LN, Shu HK (2004) Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 58(3):714–720. doi:10.1016/S0360-3016(03)01570-0
Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, Shine B, Turner HE, Wass JA (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol 62(4):397–409. doi:10.1111/j.1365-2265.2005.02231.x
Pemberton LS, Dougal M, Magee B, Gattamaneni HR (2005) Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother Oncol 77(1):99–104. doi:10.1016/j.radonc.2005.04.015
Moon SH, Kim IH, Park SW, Kim I, Hong S, Park CI, Wang KC, Cho BK (2005) Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas–a study in single institute. Childs Nerv Syst 21(8–9):799–807. doi:10.1007/s00381-005-1189-2
Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C, Xiong X, Boop FA, Sanford RA (2006) Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg 104(2 Suppl):94–102. doi:10.3171/ped.2006.104.2.5
Nagata T, Goto T, Ichinose T, Mitsuhashi Y, Tsuyuguchi N, Ohata K (2010) Pathological findings of fusiform dilation of the internal carotid artery following radical dissection of a craniopharyngioma. J Neurosurg Pediatr 6(6):567–571. doi:10.3171/2010.9.PEDS10280
Bendszus M, Sorensen N, Hofmann E, Roll E, Solymosi L (1998) Fusiform dilatations of the internal carotid artery following surgery for pediatric suprasellar tumors. Pediatr Neurosurg 29(6):304–308
Hoffmann A, Warmuth-Metz M, Lohle K, Reichel J, Daubenbuchel AM, Sterkenburg AS, Muller HL (2016) Fusiform dilatation of the internal carotid artery in childhood-onset craniopharyngioma: multicenter study on incidence and long-term outcome. Pituitary 19(4):422–428. doi:10.1007/s11102-016-0722-5
Regine WF, Mohiuddin M, Kramer S (1993) Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 27(1):13–21
Habrand JL, Ganry O, Couanet D, Rouxel V, Levy-Piedbois C, Pierre-Kahn A, Kalifa C (1999) The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 44(2):255–263
Bulow B, Attewell R, Hagmar L, Malmstrom P, Nordstrom CH, Erfurth EM (1998) Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab 83(11):3897–3904
Pereira AM, Schmid EM, Schutte PJ, Voormolen JH, Biermasz NR, van Thiel SW, Corssmit EP, Smit JW, Roelfsema F, Romijn JA (2005) High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol 62(2):197–204. doi:10.1111/j.1365-2265.2004.02196.x
Fisher PG, Jenab J, Gopldthwaite PT, Tihan T, Wharam MD, Foer DR, Burger PC (1998) Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst 14(10):558–563
Tomita T, Bowman RM (2005) Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital. Childs Nerv Syst 21(8–9):729–746. doi:10.1007/s00381-005-1202-9
Muller HL, Gebhardt U, Pohl F, Flentje M, Emser A, Warmuth-Metz M, Kolb R, Calaminus G, Sorensen N (2006) Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. Klin Padiatr 218(6):315–320. doi:10.1055/s-2006-942249
Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH (2003) Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 40(4):214–218. doi:10.1002/mpo.10247
Khafaga Y, Jenkin D, Kanaan I, Hassounah M, Al Shabanah M, Gray A (1998) Craniopharyngioma in children. Int J Radiat Oncol Biol Phys 42(3):601–606
Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB (2008) Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr 1(2):126–130. doi:10.3171/PED/2008/1/2/126
Scott RM, Hetelekidis S, Barnes PD, Goumnerova L, Tarbell NJ (1994) Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma–a 20-year experience. Pediatr Neurosurg 21(Suppl 1):75–81
Visser J, Hukin J, Sargent M, Steinbok P, Goddard K, Fryer C (2010) Late mortality in pediatric patients with craniopharyngioma. J Neuro Oncol 100(1):105–111. doi:10.1007/s11060-010-0145-5
Cohen M, Bartels U, Branson H, Kulkarni AV, Hamilton J (2013) Trends in treatment and outcomes of pediatric craniopharyngioma, 1975–2011. Neuro Oncol 15(6):767–774. doi:10.1093/neuonc/not026
Bartlett JR (1971) Craniopharyngiomas—a summary of 85 cases. J Neurol Neurosurg Psychiatry 34(1):37–41
Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90(2):237–250. doi:10.3171/jns.1999.90.2.0237
Petito CK, DeGirolami U, Earle KM (1976) Craniopharyngiomas: a clinical and pathological review. Cancer 37(4):1944–1952
Daubenbuchel AM, Hoffmann A, Gebhardt U, Warmuth-Metz M, Sterkenburg AS, Muller HL (2015) Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke’s pouch: impact on long-term prognosis. Eur J Endocrinol 172(5):561–569. doi:10.1530/EJE-14-1029
Pickering L, Jennum P, Gammeltoft S, Poulsgaard L, Feldt-Rasmussen U, Klose M (2014) Sleep-wake and melatonin pattern in craniopharyngioma patients. Eur J Endocrinol 170(6):873–884. doi:10.1530/EJE-13-1025
Ozyurt J, Lorenzen A, Gebhardt U, Warmuth-Metz M, Muller HL, Thiel CM (2014) Remote effects of hypothalamic lesions in the prefrontal cortex of craniopharygioma patients. Neurobiol Learn Mem 111:71–80. doi:10.1016/j.nlm.2014.03.007
Ozyurt J, Muller HL, Thiel CM (2015) A systematic review of cognitive performance in patients with childhood craniopharyngioma. J Neuro Oncol 125(1):9–21. doi:10.1007/s11060-015-1885-z
Zada G, Kintz N, Pulido M, Amezcua L (2013) Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS One 8(11):e76562. doi:10.1371/journal.pone.0076562
Crespo I, Santos A, Webb SM (2015) Quality of life in patients with hypopituitarism. Curr Opin Endocrinol Diabetes Obes 22(4):306–312. doi:10.1097/MED.0000000000000169
Crespo I, Valassi E, Santos A, Webb SM (2015) Health-related quality of life in pituitary diseases. Endocrinol Metab Clin N Am 44(1):161–170. doi:10.1016/j.ecl.2014.10.013
Holmer H, Popovic V, Ekman B, Follin C, Siversson AB, Erfurth EM (2011) Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma. Eur J Endocrinol 165(1):25–31. doi:10.1530/EJE-11-0229
Muller HL, Schneider P, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sorensen N (2003) Volumetric bone mineral density in patients with childhood craniopharyngioma. Exp Clin Endocrinol Diabetes 111(3):168–173. doi:10.1055/s-2003-39789
Erfurth EM, Holmer H, Fjalldal SB (2013) Mortality and morbidity in adult craniopharyngioma. Pituitary 16(1):46–55. doi:10.1007/s11102-012-0428-2
Szeifert GT, Sipos L, Horvath M, Sarker MH, Major O, Salomvary B, Czirjak S, Balint K, Slowik F, Kolonics L et al (1993) Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases. Acta Neurochir 124(2–4):139–143
Muller HL (2012) Craniopharyngioma—a childhood and adult disease with challenging characteristics. Front Endocrinol (Lausanne) 3:80. doi:10.3389/fendo.2012.00080
Funding
The author is supported by the German Childhood Cancer Foundation, Bonn, Germany.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
This manuscript was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethical approval
This review article does contain results of studies with human participants or animals performed by the author (KRANIOPHARYNGEOM 2000—NCT00258453; KRANIOPHARYNGEOM 2007—NCT01272622) and approved by the ethical committee.
Informed consent
Informed consent was obtained from all individual participants included in KRANIOPHARYNGEOM 2000 (NCT00258453) and KRANIOPHARYNGEOM 2007 (NCT01272622).
Rights and permissions
About this article
Cite this article
Müller, H.L. Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary 20, 267–281 (2017). https://doi.org/10.1007/s11102-016-0751-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-016-0751-0